SCHEMBL13350271

SCHEMBL13350271

O=C(Nc1c(Cl)cncc1Cl)c1ccc(O)c(O)c1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 11/20 0.62
TOP1 P11387 3/20 0.56
PDE4A P27815 10/20 0.55
PDE4B Q07343 10/20 0.55
PDE4C Q08493 10/20 0.55
TERT O14746 1/20 0.53
CYP2B6 P20813 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAPT P10636 1/20 0.49
SNCA P37840 1/20 0.49
ABCB11 O95342 1/20 0.46
TYK2 P29597 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30614194 0.83 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL2908650 0.83 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL717213 0.80 PDE4D (0.66) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL15085259 0.77 PDE4D (0.77) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL3237987 0.77 TYK2 (0.60) PDE4DPDE4APDE4BPDE4CTYK2
SCHEMBL15270505 0.77 PDE4D (1.00) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL720381 0.76 PDE4D (0.73) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL4037514 0.76 PDE4D (0.56) PDE4DPDE4APDE4BPDE4CMAPT
SCHEMBL13350268 0.75 PDE4D (0.67) PDE4DPDE4APDE4BPDE4CCYP2B6
SCHEMBL1553996 0.75 PDE4D (0.61) PDE4DPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822929-B1 PROCESS FOR PREPARATION OF ROFLUMILAST SCINOPHARM (CHANGSHU) PHARMACEUTICALS LTD (CN) 2017-06-14 EP disclosed
WO-2012155812-A1 PROCESSES FOR THE PREPARATION OF ROFLUMILAST AND INTERMEDIATES THEREOF 上海特化医药科技有限公司 (CN) 2012-11-22 WO disclosed
EP-2193808-A1 Synergistic combination Nycomed GmbH (DE) 2010-06-09 EP disclosed
EP-1849468-A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist Nycomed GmbH (DE) 2007-10-31 EP disclosed